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Background: In patients with community-acquired pneumonia (CAP), short-term mortality is largely dependent
on pneumonia severity, whereas long-term mortality is considered to depend on comorbidity. However, evidence
indicates that severity scores used to assist management decisions at disease onset may also be associated with
long-term mortality. Therefore, the objective of the study was to investigate the performance of the pneumonia
severity scores CURB-65 and CRB-65 compared to the Charlson Comorbidity Index (CCI) for predicting 1-year
mortality in adults discharged from hospital after inpatient treatment for CAP.
Methods: From a single centre, all cases of patients with CAP treated consecutively as inpatients between 2005
and 2009 and surviving at least 30 days after admission were analysed. The patients’ vital status was obtained from
the relevant local register office. CURB-65, CRB-65 and CCI were compared using receiver operating characteristics
(ROC) analysis.
Results: Of 498 cases analysed, 106 (21.3%) patients died within 1 year. In univariate analysis, age ≥65 years, nursing
home residency, hemiplegia, dementia and congestive heart failure were significantly associated with mortality.
CURB-65, CRB-65 and CCI were also all associated with mortality at 1 year. ROC analysis yielded a weak, yet comparable
test performance for CURB-65 (AUC and corresponding 95% confidence interval [CI] for risk categories: 0.652 [0.598-0.706])
and CCI (AUC [CI]: 0.631 [0.575-0.688]; for CRB-65 0.621 [0.565-0.677] and 0.590 [0.533-0.646]).
Conclusions: Neither CURB-65 or CRB-65 nor CCI allow excellent discrimination in terms of predicting longer term
mortality. However, CURB-65 is significantly associated with long-term mortality and performed equally to the CCI in
this respect. This fact may help to identify CAP survivors at higher risk after discharge from hospital.Background
Community acquired pneumonia (CAP) is the major cause
of mortality from infectious diseases in western countries.
In 2011, around 20,000 patients in Germany died due to
pneumonia and influenza [1]. It is notable that more than
18,000 of these patients were 65 or older at date of death
[1]. The estimated national incidence of CAP ranges from
400,000 to 680,000 infections per year [2]. National and
international guidelines recommend assessing the severity* Correspondence: ulrich.thiem@rub.de
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unless otherwise stated.of CAP at initial presentation [3,4]. Several risk scores
such as the CURB-65 [5] or the pneumonia severity index
(PSI) [6] have been developed to assist initial management
decisions. For CURB-65, for each risk factor present (con-
fusion, urea >7 mmol/L, respiratory rate ≥30 per minute,
low systolic [<90 mm Hg] or diastolic blood pressure
[<60 mm Hg] and age ≥65 years), 1 point is awarded. An
even simpler derivate, the CRB-65, which omits the urea
criterion, is recommended and is in use. Both CURB-65
and CRB-65 have been validated for short-term mortality
and permit a stratification of patients into 3 risk classes
(‘low risk’, ‘intermediate risk’ and ‘high risk’) [7-11].
Besides remarkable hospital mortality, research from the
recent years shows alarming long-term mortality among
patients who were discharged as clinically recovered aftertral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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to be strongly and independently associated with comor-
bidity, as studies consistently report [12,15,17-19]. A well-
known method for classifying comorbid conditions is the
Charlson Comorbidity Index (CCI) [22,23]. With respect
to the number and severity of comorbid conditions, this
method estimates the risk of dying in the following years.
The CCI has been validated for short-term and long-term
outcome in different study samples [24].
Apart from comorbidity, several studies report that
pneumonia severity on admission has also an influence
on long-term mortality [13,14,16,17,25]. These studies
indicate that pneumonia severity scores may be helpful
for the prediction of long-term outcome. Studies have
focused mainly on the Pneumonia Severity Index (PSI)
[13,14,16,17,25]. This rather complex index based on
demographic characteristics, comorbid illness, physical
examination and radiographic and laboratory findings is
heavily weighted by age and comorbidity [6]. At present,
it is not clear whether simpler pneumonia severity scores
such as the CURB-65 or CRB-65 are also useful in the
prediction of long-term outcome in CAP patients. There-
fore, the aim of our study was to investigate the perform-
ance of the CURB-65 and CRB-65 pneumonia severity
scores compared to the CCI for the prediction of 1-year
mortality in adults discharged from hospital after inpatient
treatment for CAP.
Methods
Setting and study population
We conducted a retrospective study at the Marienhospital
Herne, Herne, Germany. Some study details and results
on short-term mortality have already been published
[26]. Data of all adult inpatients ≥ 18 years hospitalised
between 2005 and 2009 with CAP were extracted from
the hospital’s CAP database. This database was estab-
lished in the year 2005 as part of the German national
quality assurance programme and includes information
about confusion due to pneumonia, respiratory rate and
blood pressure upon hospital admission, age, nursing
home residency, immobility, mechanical ventilation and
whether or not treatment was discontinued or not per-
formed. These variables are assessed and documented
during the hospital stay of the given patient. Additional
International Classification of Diseases (ICD-10) codes
as well as laboratory values documented during the
hospital stay were obtained from the hospital information
technology system. On the basis of this data, CURB-65
and CRB-65 [5] were calculated, as previously described.
The CCI is a weighted comorbidity index [22] that lists
nineteen diseases and conditions with major impact on
survival, for example heart, liver and kidney failure,
chronic lung diseases, diabetes, hemiplegia, cancer,
leukemia and AIDS. For each condition, between oneand six points are awarded and summed up for the
summary score. Higher score sums indicate higher
mortality [22]. To retrieve the conditions from the
administrative data set, we used the ICD-10 code list as
published by Quan et al. [23]. Information about the
patients’ vital status and/or date of death was obtained
from the relevant local register office.
To validate CAP diagnosis, all cases in the database were
reviewed. We included those cases with typical clinical
symptoms of pneumonia (at least 1 of the symptoms dys-
pnoea, cough, new sputum production or temperature ≥
38.0°C) and with either newly shown pulmonary infiltrate
on chest x-ray or elevated biochemical markers of inflam-
mation within 48 hours of hospital admission with no
evidence of other infectious diseases. Patients who had
undergone radiotherapy or chemotherapy within 28 days
prior to admission or with known immunodeficiency of
other causes were excluded. Patients with nosocomial
pneumonia and pneumonia due to other causes, e.g.
stenosis-induced pneumonia or pneumonia following
pulmonary embolism, as well as patients suffering from
acute exacerbation of chronic obstructive disease were
also excluded. Patients who had not undergone or discon-
tinued treatment, those referred from other hospitals
and patients on mechanical ventilation upon admission
were considered ineligible for inclusion. The study was
restricted to inpatients who survived the initial admis-
sion for CAP for at least 30 days.
Sample size and statistical analysis
For the purpose of this study, we used a dichotomous
risk factor for 1-year mortality, ‘low risk’ versus ‘high
risk’, as defined, for example, by CCI or CURB-65. On
the basis of data from Hsu et al. [27], we assumed a
mortality of 20% in the low-risk group and 32% in the
high-risk group, corresponding to a relative risk of 1.6.
Using Fisher’s exact test for independent samples with a
significance level of 5% and a power of 80%, we calcu-
lated about 226 cases per group or about 452 patients
in total.
Categorical variables are presented in absolute num-
bers and proportions, continuous variables with median,
mean and range. Risk stratification for all patients was
calculated on the basis of CURB-65, CRB-65 and CCI
by score points and risk categories, respectively. The
association between categorical variables was assessed
using a chi-square test. For multivariate analysis, logistic
regression analysis was used, with one model for each of
the scores in use. In all models, death within 365 days
after hospital admission was the dependent variable,
coding ‘1’ for death and ‘0’ for being alive. As explana-
tory variables, we used age (dichotomous, using median
age as cut-off ), sex and the score in three categories,
respectively. Receiver operating characteristics (ROC)
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egories of CURB-65, CRB-65 and CCI. The area under
the ROC curve (AUROC) was calculated with corre-
sponding 95% confidence intervals (CI). As the primary
endpoint, we use death from any cause at 1 year after
hospital admission for CAP.
To calculate the sample size, we used StatsDirect
Software (version 2.7.9, 2012, StatsDirect Ltd., UK). All
other analyses were performed with SPSS for Windows
(version 21, 2012, IBM Inc., USA).Results
Data of 587 inpatients with CAP were extracted from the
hospital´s CAP database. Patients referred from other
hospitals (4 patients), those who either discontinued or
did not undergo treatment (18 patients) and patients
on mechanical ventilation on admission (six patients)
were excluded. Of 559 remaining patients, 61 died
within 30 days after admission, leaving 498 patients for
analysis. Baseline characteristics of the study sample
are presented in Table 1.
The patients’ median age was 77.7 years (mean 73.0,
range 18.1 to 104.2). 279 patients were male (56.0%).
Functional impairment was prevalent in the study sam-
ple, with 111 patients being nursing home residents
(22.3%). Comorbid conditions such as congestive heart
failure (105 patients, 21.1%), dementia (140 patients,
28.1%), and diabetes mellitus (144 patients, 28.9%) were
also frequent. 417 patients (83.7%) scored at least 1
point according to the CCI and 303 individuals (60.8%)
had advanced comorbidity. In terms of pneumonia
severity, 205 patients (41.2%) were classified into the
CURB-65-defined low-risk group, whereas 293 patients
(58.8%) were at intermediate or high risk. With CRB-65,
86 patients scored 0 points and hence were classified
into the low-risk group.Table 1 Characteristics of the study sample
Characteristics Total (n = 498) Su
n % n
Age ≥65 years1 379 76.1 279
Sex (male) 279 56.0 230
Nursing home residency1 111 22.3 71
Hemiplegia1 36 7.2 20
Congestive heart failure1 105 21.1 73
Chronic lung disease 146 29.3 123
Chronic kidney disease 128 25.7 99
Diabetes 144 28.9 106
Cerebrovascular disease 98 19.7 59
Dementia1 140 28.1 89
1Statistically significant difference between survivors and non-survivors (p < 0.05).Of 498 patients, 106 (21.3%) died within 1 year. Table 1
illustrates the association of patients’ characteristics and
comorbid conditions among survivors and those who
died within 1 year of admission. Univariate analysis
showed a statistically significant association with 1-year
CAP mortality for age ≥65 years, nursing home resi-
dency, hemiplegia, dementia and congestive heart fail-
ure. The association between CCI and the CURB-65
and CRB-65 pneumonia severity scores with 1-year
mortality was also statistically significant. Overall, 1-
year mortality increased with higher score points and
risk categories for CCI as well as for CURB-65 and
CRB-65 (Table 2). These findings were similar after ad-
justments for age and gender (data not shown).
ROC analysis yielded a weak, yet comparable test
performance for CURB-65 and CCI. AUROC values
and corresponding CI for score points and risk categor-
ies, respectively, were as follows: for CURB-65 0.658
[0.606-0.711] and 0.652 [0.598-0.706]; for CRB-65 0.621
[0.565-0.677] and 0.590 [0.533-0.646]; and for CCI
0.647 [0.592-0.702] and 0.631 [0.575-0.688]. The ROC
curves for risk categories are shown in Figure 1.
Discussion
The main finding of our study is that none of the scores
performed satisfactorily in predicting 1-year mortality
after inpatient treatment of predominantly older adults
with CAP. It is noteworthy, however, that the simple
CURB-65 pneumonia severity score appears to be on
par with the CCI in this respect. This result may be
surprising, given the importance of comorbidity for the
long-term outcome of CAP [12,15,17-19]. Our analysis
confirms the role of comorbid conditions as assessed by
the CCI, as already highlighted by previous studies. In a
recent analysis of 1,117 patients, Capelastegui et al.
showed that the CCI is an independent predictor of 90-












Table 2 1-year mortality stratified by score points and
risk categories
Severity score Score points Total Mortality
(n = 498) n %
CURB-65 0 72 3 4.2
1 133 14 10.5
2 177 56 31.6
3 97 28 28.9
4 18 5 27.4
5 1 0 0.0
CRB-65 0 86 4 4.7
1 248 54 21.8
2 131 39 29.8
3 30 8 26.7
4 3 1 33.3
CCI 0 81 6 7.4
1 114 14 12.3
2 94 24 25.5
3 81 25 30.9
4 52 11 21.2
5 43 17 39.5
6 17 2 11.8
7 8 3 37.5
8 5 1 20.0
9 3 3 100.0
Severity score Score points Total Mortality
(n = 498) n %
CURB-65 Low risk 205 17 8.3
Intermediate risk 177 56 31.6
High risk 116 33 28.4
CRB-65 Low risk 86 4 4.7
Intermediate risk 379 93 24.5
High risk 33 9 27.3
CCI Low risk 195 20 10.3
Intermediate risk 175 49 28.0
High risk 128 37 28.9
Definition of risk categories:
CURB-65: low risk = 0-1 points, intermediate risk = 2 points, high risk = 3-5 points.
CRB-65: low risk = 0 points, intermediate risk = 1-2points, high risk = 3-4 points.
CCI: low risk = 0-1 points, intermediate risk = 2-3 points, high risk ≥ 3points.
Chi-square test for all associations: p < 0.001.
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predict long-term outcome in a CAP study sample with
an average follow-up of 7.5 years [15].
Contrary to the CCI, the CURB-65 and CRB-65 scores
are viewed as markers of disease severity on admission
similar to the PSI. Each of the pneumonia severity scores
is well validated for predicting 30-day CAP mortality [7].The simpler CURB-65 and CRB-65 scores differ from
the more complex PSI, as they do not heavily weight age
nor include comorbidity. Mortensen et al. demonstrated
that a higher initial PSI class is significantly associated
with decreased long-term survival [18]. Similarly, in a
recent study with 3,284 CAP patients, Johnstone et al.
showed that long-term outcome is strongly associated
with the initially calculated PSI class [16]. They hypothe-
sised that the PSI may be a marker of an individual’s
overall health status and risk of death from an episode
of acute illness rather than a true marker of pneumonia
severity [16]. Another explanation could be that pneu-
monia severity is dependent on the health status before
pneumonia onset. This would explain our finding that
scores such as CURB-65 and CRB-65, although they do
not include variables of comorbidity, are also related to
1-year mortality after CAP. Our finding is in line with
one study reporting an independent association of the
CURB score, a variant omitting the age criterion, with
adverse outcomes 90 days after hospitalisation for CAP
[28], and a further study by Krüger et al. showing an
association between 180-day mortality and CRB-65 [29].
Although not satisfying as prognostic tests, the relation-
ship between CURB-65 and CRB-65 and 1-year mortality
may be helpful for clinicians, as no other gold standard is
available. Compared to more complex tools such as CCI
or PSI, the advantages of the CURB-65 and CRB-65 are
striking: the scores are easy to calculate on admission even
in a busy emergency department; CURB-65 and CRB-65
scores are already implemented in current guidelines for
site-of-care decisions [3,4]; for most inpatients, the calcu-
lation is performed on admission, so that the calculated
score is readily available on hospital discharge.
The fact that surveillance needs to be improved has
once again been demonstrated with our study. We found
that more than one-fifth of patients who survived the
index hospitalisation due to CAP died within 1 year after
admission. Hsu et al. found that 17% of CAP hospital
survivors and 34.4% of hospital survivors of health care-
associated pneumonia (HCAP) died within the first year
following discharge [27]. Kaplan et al. reported a 1-year
mortality of 33.6% among 141,498 patients aged 65 years
or older who survived hospital treatment for pneumonia
[19]. In conclusion, long-term-mortality of inpatients sur-
viving hospitalisation for CAP is striking and found to be
sustainably higher than that of the general population
[12,20].
Apart from CCI, CURB-65 and CRB-65, several other
variables were associated with increased 1-year mortality
in our sample, including age ≥65 years, nursing home
residency, hemiplegia, dementia and congestive heart
failure. Nursing home residency and impaired cognitive
function have already been described as risk factors for
unfavourable long-term outcome in CAP patients, along
Figure 1 Receiver operating characteristics (ROC) curves for risk categories.
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[12,17,18,27,30,31]. In a recent study with 897 patients,
Yende et al. suggested an explanation for the link between
pneumonia and cardiovascular death [14]. They found
that elevated haemostasis markers are common in CAP
patients on hospital discharge. This postinflammatory
prothrombotic state was offered as an explanation for the
increased risk of all causes of mortality and cardiovascular
death over 1 year after hospitalisation for CAP. If so,
surveillance should focus on patients of advanced age
and with functional deficits as well as those with car-
diovascular comorbidity.
Several limitations of the current study should be
acknowledged. First, we performed a retrospective study,
and we used registry data for analysis. However, we do
not believe that this affects the validity of our findings.
The data in use were mainly assessed and documented
during the hospital stay of a given patient. All variables
of the pneumonia severity scores were included, with
the exception of blood urea levels. As blood urea is part
of the standard laboratory measurements obtained for
any hospital admission, urea values could be retrieved
from the hospital’s information technology system for all
cases. The CCI was calculated using ICD-10 codes from
administrative data with a well-validated method. Finally,
the primary endpoint, death from any cause 1 year after
admission, was assessed using data from the city’s local
register office, which is reliable even when performed
retrospectively.
Second, only inpatients with pneumonia were included
in our analysis. Current guidelines recommend outpatienttreatment for CAP only for CURB-65 or CRB-65-defined
low-risk patients and in the absence of advanced comor-
bidity. It is therefore unlikely that patients from risk
groups other than the low-risk group were missed.
However, this cannot be verified with our data, and
hence our findings cannot be transferred to outpatients
with CAP without reservation.
Third, findings were made in predominantly elderly
patients with high prevalence of comorbid diseases and
from a single centre only. Therefore, our findings also
need to be validated in other samples and settings.
Conclusions
In conclusion, our findings demonstrate substantial 1-year
mortality in hospital survivors of CAP. Neither CURB-65
or CRB-65 nor CCI allow excellent discrimination in
terms of predicting longer term mortality. Despite its
simplicity, CURB-65 is significantly associated with long-
term mortality and performed equally to the CCI in this
respect. This fact may help to identify patients at higher
risk after discharge from hospital. Further research is
needed on prognostic markers as well as surveillance
and rehabilitation for CAP patients who are considered
clinically cured to reduce long-term mortality.
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